Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Randomized Control Trial of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Sponsor: Clinical Center Office of the Associates Director for Radiologic&Imaging Sciences
Terminated
Study was closed due to low accrual.
This PHASE2 trial investigates Adrenal Neoplasm and Cushing Syndrome and is currently terminated or withdrawn. Clinical Center Office of the Associates Director for Radiologic&Imaging Sciences leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jul 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Terminated PHASE2
Status: Completed → Terminated
▶ Show 3 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2017 — Mar 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE2
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clinical Center Office of the Associates Director for Radiologic&Imaging Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .